Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

6.982 -0.328 (-4.49%)
Streaming Delayed Price Updated: 3:56 PM EST, Jan 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
30 31 Next >
News headline image
Psychedelic Stock Gainers And Losers From March 20, 2023 ↗
 
Via Benzinga
News headline image
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga
News headline image
The "Rags-To-Riches" Portfolio: An Update ↗
Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From March 17, 2023 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Where Compass Pathways Stands With Analysts ↗
 
Via Benzinga
News headline image
Earnings Preview: Compass Pathways ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
COMPASS Pathways: New Data & Insight On Psilocybin Therapy For Treatment-Resistant Depression ↗
COMPASS Pathways' (NASDAQ: CMPS) Phase 2b study of synthetic psilocybin COMP360 paired with psychological support for Treatment-Resistant Depression (TR 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 9, 2023 ↗
 
Via Benzinga
News headline image
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More ↗
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been... 
Via Benzinga
News headline image
Compass Pathways - Entering A Brave New World ↗
A look at what Compass Pathways is focused on, its clinical trial progress to date, its latest quarterly financials, the history of its stock price performance, and the price forecasts for the stock... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From March 6, 2023 ↗
 
Via Benzinga
News headline image
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
News headline image
2 Potentially Explosive Growth Stocks Down 30% or More to Buy for the Next Bull Market ↗
Investing now is an admittedly risky bet, but the payoff could be massive. 
Via The Motley Fool
News headline image
2 Growth Stocks With Incredible Potential in the Next 5 Years ↗
Neither is profitable, but both could be on the verge of massive booms in revenue. 
Via The Motley Fool
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 2, 2023 ↗
 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 28, 2023 ↗
 
Via Benzinga
News headline image
COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials ↗
Mental healthcare biotech COMPASS Pathways (NASDAQ: CMPS) reported its financial results for the fourth quarter and year-end 2022 and provided an update on recent pipeline and business progress.... 
Via Benzinga
News headline image
Compass Pathways Plc (CMPS) Q4 2022 Earnings Call Transcript ↗
CMPS earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results and Business Highlights
From COMPASS Pathways
Via GlobeNewswire
News headline image
Psychedelic Stock Gainers And Losers From February 27, 2023 ↗
 
Via Benzinga
News headline image
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD ↗
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage... 
Via Talk Markets
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.